Contributions of Tumor and Stromal Matrix Metalloproteinases to Tumor Progression, Invasion and Metastasis

Overview

Journal Cancer Metastasis Rev

Specialty Oncology

Date 1995 Dec 1

PMID 8821095

Citations 88

Authors

J R MacDougall

L M Matrisian

Affiliations

Soon will be listed here.

Abstract

The malignant progression of tumors is driven by the expression of oncogenes and loss of expression of tumor suppressor genes; factors that are intrinsic to cancer cells. The phenotypic changes brought about by the gain or loss of expression of oncogenes and tumor suppressor genes lead to the acquisition of malignant traits, namely, the ability to invade into and grow in ectopic tissue environments. Recently, however, focus in cancer research has widened from the cancer cell to include the surrounding tumor stroma as an integral player in the process of tumor progression. One of the areas in cancer research contributing to this enhanced appreciation of stromal involvement in tumor progression and metastasis is that of matrix metalloproteinases (MMPs). This review provides an overview of the characteristics of MMPs and discusses their role in the progression and metastasis of tumors. Initially, attention will focus on the regulation of MMPs in tumor cells but will switch to discourse on stromal expression of MMPs in tumors and speculation on the functional consequences of stromal expression of MMPs.

Citing Articles

Chlorogenic Acid: A Systematic Review on the Biological Functions, Mechanistic Actions, and Therapeutic Potentials.

Nguyen V, Taine E, Meng D, Cui T, Tan W Nutrients. 2024; 16(7).

PMID: 38612964 PMC: 11013850. DOI: 10.3390/nu16070924.

Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers.

Banerjee S, Ansari A, Upadhyay S, Mettman D, Hibdon J, Quadir M Cells. 2024; 13(5.

PMID: 38474359 PMC: 10930662. DOI: 10.3390/cells13050395.

NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype.

Oh A, Pardo M, Rodriguez A, Yu C, Nguyen L, Liang O Cell Commun Signal. 2023; 21(1):291.

PMID: 37853467 PMC: 10585759. DOI: 10.1186/s12964-023-01207-z.

Advances in protein glycosylation and its role in tissue repair and regeneration.

Yue Z, Yu Y, Gao B, Wang D, Sun H, Feng Y Glycoconj J. 2023; 40(3):355-373.

PMID: 37097318 DOI: 10.1007/s10719-023-10117-8.

Recent Progress in Small Spirocyclic, Xanthene-Based Fluorescent Probes.

G Keller S, Kamiya M, Urano Y Molecules. 2020; 25(24).

PMID: 33339370 PMC: 7766215. DOI: 10.3390/molecules25245964.

References

Kataoka H, DeCastro R, Zucker S, Biswas C . Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res. 1993; 53(13):3154-8. View

Gross J, Lapiere C . Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A. 1962; 48:1014-22. PMC: 220898. DOI: 10.1073/pnas.48.6.1014. View

Johnson M, Kim H, Chesler L, BOUCK N, Polverini P . Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol. 1994; 160(1):194-202. DOI: 10.1002/jcp.1041600122. View

Koop S, Khokha R, Schmidt E, MacDonald I, Morris V, Chambers A . Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res. 1994; 54(17):4791-7. View

Wilson C, Heppner K, Rudolph L, Matrisian L . The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Mol Biol Cell. 1995; 6(7):851-69. PMC: 301245. DOI: 10.1091/mbc.6.7.851. View

Crouch E, Parks W . Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol. 1995; 105(2):190-6. DOI: 10.1111/1523-1747.ep12317104. View

Powell W, KNOX J, Navre M, Grogan T, Kittelson J, Nagle R . Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res. 1993; 53(2):417-22. View

MacDougall J, Kerbel R . Constitutive production of 92-kDa gelatinase B can be suppressed by alterations in cell shape. Exp Cell Res. 1995; 218(2):508-15. DOI: 10.1006/excr.1995.1185. View

Pajouh M, Nagle R, Breathnach R, FINCH J, Brawer M, Bowden G . Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol. 1991; 117(2):144-50. DOI: 10.1007/BF01613138. View

10.

Yamamoto H, Itoh F, Hinoda Y, Senota A, Yoshimoto M, Nakamura H . Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin. Biochem Biophys Res Commun. 1994; 201(2):657-64. DOI: 10.1006/bbrc.1994.1751. View

11.

Emonard H, Remacle A, Noel A, Grimaud J, Stetler-Stevenson W, Foidart J . Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase. Cancer Res. 1992; 52(20):5845-8. View

12.

Alexander C, Werb Z . Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol. 1989; 1(5):974-82. DOI: 10.1016/0955-0674(89)90068-9. View

13.

Overall C, Wrana J, Sodek J . Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem. 1991; 266(21):14064-71. View

14.

Khokha R, Zimmer M, Graham C, Lala P, Waterhouse P . Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst. 1992; 84(13):1017-22. DOI: 10.1093/jnci/84.13.1017. View

15.

Bernhard E, Muschel R, Hughes E . Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res. 1990; 50(13):3872-7. View

16.

Alvarez O, Carmichael D, DeClerck Y . Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst. 1990; 82(7):589-95. DOI: 10.1093/jnci/82.7.589. View

17.

Werb Z, Tremble P, Behrendtsen O, Crowley E, Damsky C . Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol. 1989; 109(2):877-89. PMC: 2115739. DOI: 10.1083/jcb.109.2.877. View

18.

Birkedal-Hansen H, Moore W, Bodden M, Windsor L, DeCarlo A, Engler J . Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993; 4(2):197-250. DOI: 10.1177/10454411930040020401. View

19.

Newell K, Witty J, Rodgers W, Matrisian L . Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog. 1994; 10(4):199-206. DOI: 10.1002/mc.2940100404. View

20.

Bernhard E, Gruber S, Muschel R . Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci U S A. 1994; 91(10):4293-7. PMC: 43771. DOI: 10.1073/pnas.91.10.4293. View